Dekvalynyya chloride | fluomizine tablets vaginal 10 mg 6 pcs.

Release form

Vaginal tablets.

Packing

6 pcs.

Pharmacological action

Pharmacotherapeutic group

Antiseptic.

ATX code: G01AC05

Pharmacological properties of

Pharmacodynamics.

Fluomisin® contains the active substance dequalinium chloride, which is a quaternary ammonium compound with a wide spectrum of antimicrobial activity. Dequalinium chloride is active against most gram-positive bacteria Streptococcus spp., Including (beta-hemolytic streptococci groups A and B), Staphylococcus aureus, Listeria spp. anaerobes Peptostreptococcus (group D), fungi of the genus Candida (Candida tropicalis, Candida albicans, Candida glabrata), gram-negative bacteria Gardnerella vaginalis, Escherichia coli, Serratia spp., Klebsiella spp., Pseudomonas spp., Proteus vagis. )

Pharmacokinetics. With intravaginal administration, an extremely small amount of dequalinium chloride is absorbed through the vaginal mucosa into the systemic circulation, metabolized to a derivative of 2,2-dicarboxylic acid, and excreted in the unconjugated form through the intestines.

Indications

• bacterial vaginosis

• candidal vaginitis

• trichomonas vaginitis

• sanitation of the vagina before gynecological surgery and childbirth.

Contraindications

Hypersensitivity to the components of the drug. Peptic ulcer of the vagina and cervix.

The use of dequalinium chloride prior to sexual activity is not recommended.

Special instructions

FluomisinВ® contains excipients that sometimes do not completely dissolve in the vagina. Therefore, the remains of a vaginal tablet can be found on underwear. This does not affect the effectiveness of FluomisinВ®.

In rare cases, with excessive dryness of the vagina, it is likely that the tablet will remain undissolved. To prevent this, before introducing a vaginal tablet, it must be moistened with water (for 1 second under running water).

During the treatment period it is recommended to change pads and underwear more often. If the clinical signs of infection persist after treatment is completed, a repeated microbiological examination should be performed to identify the pathogen and confirm the diagnosis.

During treatment with the drug, it is recommended to refrain from sexual intercourse. To prevent urogenital reinfection, simultaneous treatment of sexual partners is necessary.

Composition

Composition per 1 tablet:

Active ingredient: dequalinium chloride 10 mg

Excipients: lactose monohydrate, microcrystalline cellulose, magnesium stearate.

Dosage and administration

Recommended dosage - 1 vaginal tablet / day. A vaginal tablet is injected deep into the vagina in the evening before bedtime, lying on its back, slightly bending its legs. During menstruation, treatment should be discontinued and the previous course continued after it is completed. It is necessary to conduct a full course of treatment (6 days) in order to avoid relapse.

Side effects

Local irritation (erosion) reactions, itching, burning or redness at the injection site are extremely rare. However, these adverse reactions may also be associated with symptoms of vaginal infection.

Extremely rare fever, allergic reaction.

Drug Interactions

Fluomisin® is not compatible with soap and other anionic surfactants.

Overdose

No overdose is available. In intravaginal use, an overdose is unlikely.

Storage Conditions

The product should be stored out of the reach of children at a temperature not exceeding 25 РC.

Shelf life

3 years. Do not use after the expiration date indicated on the package.

Active ingredient

Dequalinium chloride

Terms and conditions

without prescription

Formulation

tablets vaginal

For

For

For women, For adults prescribed by a doctor

Medinova, Switzerland